Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extreme Hodgkin's lymphoma: current problem areas.

S J Proctor1, J Wilkinson

  • 1Department of Haematological Oncology, University of Newcastle-upon-Tyne, UK. S.J.Proctor@newcastle.ac.uk

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|May 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SWAT 116: the effectiveness of an infographic to improve trial recruitment-a randomised study within a trial (SWAT).

Trials·2026
Same author

SWAT 119: the effectiveness of a Thank You card to improve trial follow-up; a randomised study within a trial (SWAT).

Trials·2026
Same author

Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2026
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025
Same author

First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

Physical review letters·2025
Same author

Rivastigmine as an alternative treatment for anticholinergic toxidrome in light of the physostigmine shortage: A case series.

The American journal of emergency medicine·2025

Risk-based therapy and web-based data collection are improving outcomes for Hodgkin

Area of Science:

  • Hematology
  • Oncology
  • Clinical Trials

Background:

  • Hodgkin's lymphoma therapy presents significant challenges, particularly for specific patient groups.
  • Current treatment strategies require refinement to address areas of difficulty in managing Hodgkin's lymphoma.
  • The need for improved therapeutic approaches and data collection in Hodgkin's lymphoma is critical.

Purpose of the Study:

  • To explore challenging areas in Hodgkin's lymphoma therapy.
  • To provide evidence for the efficacy of risk-related therapy and web-based data collection programs.
  • To highlight the need for novel salvage regimens and improved treatment evaluation for elderly patients.

Main Methods:

  • Analysis of unpublished data from the UK on risk-based therapy for young Hodgkin's lymphoma patients.

Related Experiment Videos

  • Review of an index developed at Memorial Sloan-Kettering Cancer Centre (MSKCC) for salvage therapy.
  • Description of the SHIELD project utilizing on-line registration for a Phase II study of VEPEMB in elderly patients.

    • Main Results:

    • Risk-based therapy shows improved outcomes in poor-prognosis Hodgkin's lymphoma patients aged 15-19 years.
    • The MSKCC index indicates an urgent need for new second-line regimens for poor-prognosis patients.
    • The SHIELD project is successfully facilitating on-line registration and ethical guidance for elderly patient trials.

    Conclusions:

    • Tailored, risk-stratified treatment is essential for both adolescent and adult Hodgkin's lymphoma patients.
    • Elderly Hodgkin's lymphoma patients are underrepresented in clinical trials, necessitating new data pooling strategies.
    • Web-based data collection and risk-based approaches, exemplified by the SHIELD project, can advance Hodgkin's lymphoma treatment.